News from NYU Langone Health
HealthLeaders
NYU Langone Health has launched "ÀÇÎѵ¼º½ Me," an innovative program designed to strengthen the bond between patients and caregivers. Leveraging the Epic EHR system, the initiative invites patients to share personal details, helping clinicians see them as individuals beyond their diagnosis. Katherine Hochman, MD, a practicing clinician and director of the Division of Hospital Medicine at NYU Langone Health, explains that taking a moment to build this connection helps establish trust, making patients more receptive to their care plans. Dr. Paul Testa, Chief Health Informatics Officer, adds that the program fosters empathy and helps restore joy in medicine. Now active on 35 hospital units, the successful initiative is planned for future expansion.
11/11/2025
WPIX-TV (New York, NY)
In a hopeful turn for Wendy Williams and her supporters, new neurological tests reportedly show the TV star does not have dementia, challenging the earlier diagnosis that placed her under legal and financial guardianship. According to PIX11 News, Williams’s legal team plans to use these findings to petition the court to end her guardianship. However, her guardian previously claimed she tested positive for frontotemporal dementia (FTD). Joel Salinas, MD, MBA, Clinical Associate Professor, Department of Neurology at NYU Grossman School of Medicine, not involved in Williams’s care, explained that FTD is difficult to diagnose and can be mistaken for other conditions like Alzheimer’s or slow-progressing medical issues. Williams, who has been sober for nearly three years, remains determined to regain her independence and end her confinement in a memory care facility in Hudson Yards.
11/10/2025
U.S. News and World Report
A new study led by John A. Dodson, MD, MPH, director of NYU Langone's Geriatric Cardiology Program and an associate professor in the Department of Medicine's Leon H. Charney Division of Cardiology at NYU Langone Health found that while financial incentives can improve medication adherence, they do not lead to better blood pressure control. The research used a daily cash lottery to reward patients for taking their blood pressure medication. While participants in the rewards group were twice as likely to take their medicine, their blood pressure readings showed no significant improvement over the control group. The improved adherence also stopped once the program ended. Dr. Dodson called the results "surprising," concluding that improving long-term medication adherence is "more complex than we thought."
11/10/2025
HMP Global Learning Network
Jordan Axelrad, MD, MPH, FACG, co-director of the Inflammatory Bowel Disease Center at NYU Langone Health and associate professor of medicine at NYU Grossman School of Medicine presented on Clostridioides difficile (C diff) infection at the American College of Gastroenterology annual meeting. He reviewed updated guidelines for C diff diagnosis, endorsing two-step testing. Standard antibiotic treatments include vancomycin or fidaxomicin. For recurrent infections, FDA-approved microbial therapeutics such as Rebyota and Vowst are now available, replacing unapproved fecal microbiota transplantation. These novel therapies may also be covered by many payers.
11/11/2025
News Medical
A study co-led by NYU Grossman School of Medicine found that a midlife blood test for platelet activity could identify Alzheimer's disease risk decades in advance. Researchers linked platelet aggregation to PET and MRI brain markers of Alzheimer's risk in middle-aged individuals. Jaime Ramos-Cejudo, PhD, assistant professor of psychiatry and neurology at NYU Langone, is the first author and principal investigator of a new $8 million grant to further study platelet activity's role in brain aging and Alzheimer's progression. This research suggests platelets may bridge vascular dysfunction and brain inflammation, opening new intervention opportunities.
11/11/2025
Trading View
A new study presented at the American Heart Association scientific meeting found stress cardiac MRI can detect microvascular angina, a heart-related chest pain often missed by standard angiography, particularly in women. Separately, research presented at the American Society of Nephrology Kidney Week 2025 highlighted that measuring both cystatin C and creatinine provides a more accurate assessment of kidney function. Morgan Grams, MD, PhD, the Susan and Morris Mark Professor of Medicine at the NYU Grossman School of Medicine and co-director of Division of Precision Medicine, stated that evaluating both biomarkers identifies more people with poor kidney function earlier by covering blind spots of individual tests.
11/11/2025
The New York Times
At an international xenotransplantation conference in Geneva, researchers expressed new optimism about ending the global shortage of donor organs. Scientists reported significant progress using organs from genetically modified pigs engineered to reduce immune rejection in humans. Two patients — a man in New England and a woman in China — survived over six months with transplanted pig kidneys before returning to dialysis. Several U.S. clinical trials are now beginning, including one by United Therapeutics involving a pig kidney with ten gene edits. Muhammad M. Mohiuddin, MD, outgoing president of the International Xenotransplantation Association, said the field’s long-awaited future has arrived. NYU Langone Health’s key role in the field is highlighted.
11/09/2025
Optometry Times
In an interview, Angela Wen, OD, clinical instructor, Department of Ophthalmology at NYU Grossman School of Medicine, discusses contemporary glaucoma care. She identifies the Humphrey field analyzer as a cornerstone technology, stressing its value over optical coherence tomography in some cases. Wen asserts that eye drops remain a vital component of therapy, even with advancements in laser and surgical interventions, due to their practicality and patient adherence. She also recommends that general optometrists build collaborative relationships with ophthalmologists to improve their confidence and competence in managing complex glaucoma cases within a multidisciplinary setting.
11/11/2025
RTT News
A new global study, co-led by scientists from NYU Langone Health, reveals that chronic kidney disease cases have more than doubled since 1990, affecting 788 million people in 2023. The research, which analyzed data from 133 countries, identifies CKD as a top 10 cause of death worldwide. Josef Coresh, MD, PhD, the Terry and Mel Karmazin Professor of Population Health, Department of Population Health and director of NYU Langone’s Optimal Aging Institute, emphasized the condition's growing public health significance. Study co-lead author Morgan Grams highlighted the need for early urine testing and accessible therapy for diagnosed patients.
Also reporting was: 
11/10/2025
MPR News (Saint Paul, MN)
Medical experts offer advice on minimizing morning aches and pains by focusing on sleep posture, pillow choice, and mattress quality. Ellen Wermter, a nurse practitioner, suggests sleeping in a position that follows the natural curvature of the spine and avoiding stomach sleeping. Fabian Morales, MD, a sports medicine physician, recommends specific pillow types and regular replacement. Charla Fischer, MD, orthopedic spine surgeon at NYU Langone Health, associate director of Spine Surgery Fellowship Program, and director of Quality and Patient Safety, Division of Spine Surgery, and site chief, Orthopedic Surgery, Tisch Hospital/Kimmel Pavilion, notes that muscle pain is common, especially with age, and advises consulting a medical professional for persistent issues, otherwise suggesting basic pain relief remedies like anti-inflammatory medication, massage, and heat.
11/10/2025
WABC-TV (New York, NY)
°Õ³ó±ð NYU Langone Military Family Center participated at a Veterans Day Parade on Fifth Avenue. The center is a big part of the university's work and has participated in the parade every year since its 2012 founding. N³Û±«â€¯and Columbia have two of the largest populations of student veterans in New York City.
11/10/2025
Archyde
Researchers at NYU Grossman School of Medicine and New York University discovered that estrogen directly influences dopamine activity, enhancing learning capabilities in females. The study, published in Nature Neuroscience, found increased estrogen boosts dopamine signaling, improving reward-based learning in laboratory rats. Christine Constantinople, PhD, professor in NYU Langone's Center for Neural Science, the study’s senior author, notes these findings have significant implications for understanding and treating neuropsychiatric disorders, suggesting personalized medicine approaches based on hormonal profiles. This research emphasizes the need for more studies on sex differences in brain function.
Also reporting was: , 
11/11/2025
Archynetys
A new injected weight loss drug, eloralintide, is progressing to late-stage clinical trials, demonstrating up to 20 percent body weight loss in mid-stage trials. This drug mimics the pancreatic hormone amylin, differing from GLP-1 medicines. Melanie Jay, MD, professor of population health at NYU Langone Health and director of the NYU Langone Comprehensive Program on Obesity, noted that eloralintide's weight loss results appear similar to tirzepatide. Jay emphasized the importance of resistance training to mitigate muscle mass loss with rapid weight loss medications and highlighted the benefit of new treatment options for patients with obesity.
11/10/2025
